{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:26:03Z","timestamp":1794471963689,"version":"4.9.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10840-019-00678-w","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T15:13:34Z","timestamp":1576163614000},"page":"415-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage"],"prefix":"10.1007","volume":"59","author":[{"given":"William J.","family":"Hucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Edip","family":"Gurol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kevin","family":"Heist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Galvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donita","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Bommana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ruskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghamitra","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"issue":"9689","key":"678_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet"},{"issue":"25","key":"678_CR2","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","volume":"61","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, M\u00f6bius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for Oral anticoagulation. J Am Coll Cardiol. 2013;61(25):2551\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"678_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/STROKEAHA.117.017081","volume":"49","author":"ME Gurol","year":"2018","unstructured":"Gurol ME. Nonpharmacological Management of Atrial Fibrillation in patients at high intracranial hemorrhage risk. Stroke. 2018;49(1):247\u201354.","journal-title":"Stroke"},{"issue":"12","key":"678_CR4","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","volume":"41","author":"A Majeed","year":"2010","unstructured":"Majeed A, Kim YK, Roberts RS, Holmstr\u00f6m M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41(12):2860\u20136.","journal-title":"Stroke"},{"issue":"3","key":"678_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cjca.2015.07.723","volume":"32","author":"P Fahmy","year":"2016","unstructured":"Fahmy P, Spencer R, Tsang M, Gooderham P, Saw J. Left atrial appendage closure for atrial fibrillation is safe and effective after intracranial or intraocular hemorrhage. Can J Cardiol. 2016;32(3):349\u201354.","journal-title":"Can J Cardiol"},{"issue":"5","key":"678_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.hrthm.2018.11.022","volume":"16","author":"E Hutt","year":"2018","unstructured":"Hutt E, Wazni OM, Saliba WI, Kanj M, Tarakji KG, Aguilera J, et al. Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage. Heart Rhythm. 2018;16(5):663\u20138.","journal-title":"Heart Rhythm"},{"issue":"4","key":"678_CR7","doi-asserted-by":"publisher","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","volume":"12","author":"LV Boersma","year":"2019","unstructured":"Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, et al. Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology. Circ Arrhythm Electrophysiol. 2019;12(4):e006841. https:\/\/doi.org\/10.1161\/CIRCEP.118.006841.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"24","key":"678_CR8","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","volume":"70","author":"GF Tomaselli","year":"2017","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, et al. 2017 ACC expert consensus decision pathway on Management of Bleeding in patients on Oral anticoagulants: a report of the American College of Cardiology Task Force on expert consensus decision pathways. J Am Coll Cardiol. 2017;70(24):3042\u201367.","journal-title":"J Am Coll Cardiol"},{"key":"678_CR9","doi-asserted-by":"crossref","unstructured":"Holmes, D. R., Kar, S., Price, M. J., Whisenant, B., Sievert, H., Doshi, S. K., \u2026 Reddy, V. Y. (2014). Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. Journal of the American College of Cardiology, 64(1), 1\u201312. D.","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"678_CR10","doi-asserted-by":"crossref","unstructured":"Majule DN, Jing C, Rutahoile WM, Shonyela FS. The efficacy and safety of the WATCHMAN device in LAA occlusion in patients with non-Valvular atrial fibrillation contraindicated to Oral anticoagulation: a focused review. Ann Thorac Cardiovasc Surg. 2018;24(6):271\u20138.","DOI":"10.5761\/atcs.ra.18-00014"},{"key":"678_CR11","doi-asserted-by":"crossref","unstructured":"Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., \u2026 Council on Clinical Cardiology. (2015). Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke, 46(7), 2032\u20132060.","DOI":"10.1161\/STR.0000000000000069"},{"issue":"6","key":"678_CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","volume":"132","author":"PB Nielsen","year":"2015","unstructured":"Nielsen PB, Larsen TB, Skj\u00f8th F, Gorst-Rasmussen A, Rasmussen LH, Lip GYH. Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and BleedingCLINICAL PERSPECTIVE. Circulation. 2015;132(6):517\u201325.","journal-title":"Circulation"},{"issue":"4","key":"678_CR13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamainternmed.2016.9369","volume":"77","author":"PB Nielsen","year":"2017","unstructured":"Nielsen PB, Larsen TB, Skj\u00f8th F, Lip GYH. Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation. JAMA Intern Med. 2017;77(4):563\u201370.","journal-title":"JAMA Intern Med"},{"key":"678_CR14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2017.02.042","volume":"236","author":"A Tzikas","year":"2017","unstructured":"Tzikas A, Freixa X, Llull L, Gafoor S, Shakir S, Omran H, et al. Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: results from the Amplatzer cardiac plug registry. Int J Cardiol. 2017;236:232\u20136.","journal-title":"Int J Cardiol"},{"issue":"3","key":"678_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.11.126","volume":"26","author":"P Renou","year":"2017","unstructured":"Renou P, Thambo J-B, Iriart X, Nicot S, Kabore N, Jalal Z, et al. Left atrial appendage closure in patients with atrial fibrillation and previous Intracerebral hemorrhage. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2017;26(3):545\u201351.","journal-title":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association"},{"key":"678_CR16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN, et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138:874\u201385.","journal-title":"Circulation"},{"key":"678_CR17","doi-asserted-by":"crossref","unstructured":"Reddy, V. Y., Doshi, S. K., Kar, S., Gibson, D. N., Price, M. J., Huber, K., Horton R.P., Buchbinder M., Neuzil P., Gordon N.T., Holmes DR Jr, PREVAIL and PROTECT AF Investigators PREVAIL and PROTECT AF Investigators. (2017). 5-year outcomes after left atrial appendage closure. J Am Coll Cardiol, 70(24), 2964\u20132975.","DOI":"10.1016\/j.jacc.2017.10.021"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-019-00678-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-019-00678-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-019-00678-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T01:32:17Z","timestamp":1607650337000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-019-00678-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1007\/s10840-019-00678-w","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"7 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"EK Heist is a consultant at Boston Scientific, Abbott. Research Grants: Boston Scientific, Abbott. L DiBiase is a consultant at Biosense Webster, Stereotaxis and speaker honoraria\/travel support at Biosense Webster, Abbott, Boston Scientific, Medtronic, Biotronik, Pfizer, Bristol-Myers Squibb. R Horton is a consultant at Biosense-Webster, Boston Scientific, Abbott. Research grants were received from Biosense-Webster, Boston Scientific, Abbott. D Lakkireddy is a consultant at Biosense-Webster, Boston Scientific, Abbott, Sentre Heart. Research grants were received from Biosense-Webster, Boston Scientific, Abbott, Sentre Heart. A Natale is a consultant at Biosense-Webster, Boston Scientific, Abbott, Medtronic. Research grants were received from Biosense-Webster, Boston Scientific, Abbott.M Mansour is a consultant at Biosense-Webster, Boston Scientific, Abbott, Medtronic, Johnson and Johnson, Janssen, Philips, Novartis, Sentre Heart. Research grants were received from Biosense-Webster, Boston Scientific, Abbott, Pfizer, Boehringer Ingelheim, Sentre Heart, Johnson and Johnson, Medtronic. He has an equity from EPS Solutions, New Pace Ltd. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}